STD Logo

Predictive AI
That Outperforms

Adds Alpha, Reduces Beta, Controls Risk
Stock Analysis

Learn to Evaluate (SBTX:LN) using the Charts

ET
By Quantitative Research Desk
Editor: Thomas H. Kee Jr.

Key findings for SkinBioTherapeutics Plc - Ordinary Shares (SBTX:LN)

  • Near-Term Strength Insufficient To Reverse Weak Trend
  • No clear price positioning signal identified.
  • Exceptional 69.2:1 reward-to-risk short setup targets 34.6% downside vs 0.5% risk
  • Long-term technical target is set at $11.99.
  • Weak Sentiment is prevailing thus far — See current SIGNALS for positioning and risk parameters.

Institutional Trading Strategies

Our AI models have generated three distinct trading strategies tailored to different risk profiles and holding periods. Each strategy incorporates sophisticated risk management parameters designed to optimize position sizing and minimize drawdown risk.

Position Trading Strategy LONG
Entry Zone
$11.99
Target
$16.60
Stop Loss
$11.93
Momentum Breakout Strategy BREAKOUT
Entry Zone
$10.85
Target
N/A
Stop Loss
$10.80
Risk Hedging Strategy SHORT
Entry Zone
$11.99
Target
$10.85
Stop Loss
$12.05

Multi-Timeframe Signal Analysis

Time Horizon Signal Strength Support Signal Resistance Signal
Near-term (1-5 days) Strong $10.85 N/A
Mid-term (5-20 days) Weak $10.85 $11.99
Long-term (20+ days) Weak $7.84 $11.99

AI Generated Signals for SBTX:LN

Stock Chart for SBTX:LN
Chart for SkinBioTherapeutics Plc - Ordinary Shares (SBTX:LN)